Following a change in screening guidelines, the incidence went up across the state, even more than it has nationally.

Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce that, effective February 1, 2025, Nova Scotia is publicly funding Pluvictotm (lutetium (177Lu) vipivotide tetraxetan ...

Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce that, effective February 1, 2025, Nova Scotia is publicly funding Pluvicto™ (lutetium (177Lu) vipivotide tetraxetan injection), ...

Revolutionizing Prostate Cancer Risk Assessment with a More Patient-Centered Approach ANN ARBOR, Mich., Feb. 03, 2025 ...

The Bank Windhoek Cancer Apple Project has raised N$38.4 million since its inception in 2000.This significant milestone was announced at an event last week on Friday, where Bank Windhoek presented a ...

There are some signs that can help in the early detection of one of the most prevalent types of cancer amongst men — and they ...

Giles Coren, esteemed restaurant critic and writer, has come forward with his prostate cancer diagnosis amid a surge in ...

Every two minutes, a man is diagnosed with prostate cancer in our country. This disease is currently the second-leading cancer-related killer of men in the United States.

GenesisCare has launched its first self-referral mpMRI prostate cancer screening service at its Oxford outpatient centre.

David James, director of patient projects and influencing at Prostate Cancer Research, has set the record straight on some of ...

Former BBC presenter says he was diagnosed with a ‘malign tumour’ after earlier refusing to undergo a biopsy ...